All Phenotypes Wrn<tm1Led> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Wrn^tm1Led/Wrn^tm1Led	B6.129S6(BKSW)-Wrn^tm1Led	MGI:3665480
hm2	Wrn^tm1Led/Wrn^tm1Led	either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss)	MGI:2383958
hm3	Wrn^tm1Led/Wrn^tm1Led	involves: 129S6/SvEvTac * Black Swiss	MGI:3665481
ht4	Wrn^tm1Led/Wrn⁺	involves: 129S6/SvEvTac * Black Swiss	MGI:3665482
cx5	Trp53^tm1Brd/Trp53^tm1Brd Wrn^tm1Led/Wrn^tm1Led	either: (involves: 129S/SvEv) or (involves: 129S/SvEv * NIH Black Swiss)	MGI:2383960
cx6	Cdkn1a^tm1Led/Cdkn1a^tm1Led Wrn^tm1Led/Wrn^tm1Led	either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss)	MGI:2383959
cx7	Tg(Hba-x-v-Ha-ras)TG.ACLed/0 Wrn^tm1Led/Wrn^tm1Led	involves: 129 * FVB/N * Black Swiss	MGI:2651804

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

growth/size/body

increased susceptibility to age related obesity ( J:106446 )

• at 5 months, all homozygotes (esp. virgin females) fed a 5% fat diet show a greater increase in body weight relative to similarly fed wild-type littermates; no differences in body weight are observed up to 4 months of age

• at 5 months, mutant virgin females exhibit a 25% increase in body weight, whereas mutant males show only a 12% increase in body weight relative to wild-type mice

adipose tissue

increased abdominal adipose tissue amount ( J:106446 )

• at 9 months, homozygotes fed a 5% fat diet show an abnormal increase in visceral fat deposition relative to wild-type mice

increased inguinal fat pad weight ( J:106446 )

• at 9 months, female and male homozygotes fed a 5% fat diet show a 4-fold and 2.5-fold increase in inguinal (subcutaneous) white adipose mass, respectively, relative to wild-type counterparts

increased retroperitoneal fat pad weight ( J:106446 )

• at 9 months, female and male homozygotes fed a 5% fat diet show a similar 3-fold increase in visceral (retroperitoneal) white adipose mass relative to wild-type mice

homeostasis/metabolism

hyperglycemia ( J:106446 )

• aging homozygotes develop hyperglycemia: at 6 and 9 months, both sexes show a similar 10% and 25% increase in fasting blood glucose levels, respectively, relative to age-matched wild-type counterparts

increased circulating insulin level ( J:106446 )

• at 6 months (but not at 3 months), female and male homozygotes show a similar 2.4-fold increase in fasting serum insulin levels relative to age-matched wild-type counterparts

increased circulating hyaluronic acid level ( J:106446 )

• at 4 months, male (but not female) homozygotes exhibit a 67% increase in serum hyaluronic acid levels relative to wild-type counterparts

increased circulating cholesterol level ( J:106446 )

• at 6 months, virgin female homozygotes show a 44% increase in fasting total cholesterol levels relative to wild-type females; no differences are noted at 3 months

• in contrast, male homozygotes show no significant differences in total cholesterol levels or HDL levels relative to wild-type males at 3 or 6 months

increased circulating triglyceride level ( J:106446 )

• at 6 months, female and male homozygotes display a 30% and 19% increase in fasting serum triglyceride levels, respectively, relative to age-matched wild-type counterparts

• however, no significant differences in serum triglyceride levels are observed at 3 or 4 months i.e. prior to the onset of age-related obesity

hyperlipidemia ( J:106446 )

insulin resistance ( J:106446 )

• at 6 months, fasting female and male homozygotes show a similar increase in insulin resistance (2.4-fold higher on the HOMA-IR index) relative to wild-type mice

cardiovascular system

aortic valve stenosis ( J:106446 )

• at 12 months, male homozygotes exhibit signs of aortic stenosis, as shown by a reduced aortic diastolic pressure and an increased ventricular systolic pressure relative to wild-type males

• however, aortic stenosis is compensated by an increased maximal contractility (dP/dt_max) and a reduced ejection time, indicating early signs of compensated cardiac functional hypertrophy at 12 months

cardiac interstitial fibrosis ( J:106446 )

• several aging homozygotes exhibit mild to severe cardiac interstitial fibrosis of the left ventricle on all genetic backgrounds studied, including an inbred 129/Sv, outbred (involving 129/Sv and Black Swiss) and congenic C57BL/6 background

increased left ventricle systolic pressure ( J:106446 )

• at 12 months, male homozygotes exhibit an increased ventricular systolic pressure relative to wild-type males

decreased systemic arterial diastolic blood pressure ( J:106446 )

• at 12 months, male homozygotes exhibit a reduced aortic diastolic pressure relative to wild-type males

cellular

cardiac interstitial fibrosis ( J:106446 )

increased cellular sensitivity to oxidative stress ( J:106446 )

• in vitro, mutant MEFs exhibit a greater increase in ROS levels after exposure to high concentrations of palmitate than wild-type MEFs

oxidative stress ( J:106446 )

• adult, but not juvenile, homozygotes exhibit severe oxidative stress followed by elevated cardiac oxidative DNA damage, all before the onset of cardiac fibrosis

• at 9 months, female homozygotes display a more severe oxidative stress, with a 2-fold higher increase in serum H₂O₂ levels and cardiac tissue reactive oxygen species relative to male homozygotes

• by 12 months, female homozygotes exhibit a 2-fold increase in cardiac oxidative DNA damage relative to wild-type females, not evident at 6 months

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
Werner syndrome		DOID:5688	OMIM:277700	J:106446

Allelic Composition	Wrn^tm1Led/Wrn^tm1Led
Genetic Background	either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss)

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Wrn^tm1Led mutation (0 available); any Wrn mutation (91 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

preweaning lethality, incomplete penetrance ( J:48424 )

• slightly reduced Mendelian ratio, suggesting some prenatal or early postnatal lethality

neoplasm

increased tumor incidence ( J:48424 )

• 62% of mice at 24 months developed hyperplasias or tumors in one of their organs

Allelic Composition	Wrn^tm1Led/Wrn^tm1Led
Genetic Background	involves: 129S6/SvEvTac * Black Swiss

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Wrn^tm1Led mutation (0 available); any Wrn mutation (91 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

cardiac interstitial fibrosis ( J:106446 )

• aging homozygotes of both sexes are more likely to develop severe cardiac fibrosis than wild-type mice; the number of affected male and female homozygotes is similar

• by 25 months (when all mutants are already dead), 65% of homozygotes have developed more severe cardiac interstitial fibrosis of the left ventricle than wild-type littermates (15%); earliest time of onset is at 5 months

• in addition, 5 of 55 homozygotes also exhibit fibrosis around major cardiac vessels or the aortic root

• calculation of cause-specific hazard rates indicates that homozygotes are more likely to develop and die from cardiac fibrosis than cancers or infections, whereas wild-type mice are more likely to die from other diseases

heart inflammation ( J:106446 )

• by 25 months, 5 of 55 homozygotes exhibiting fibrosis of the aortic root also show evidence of inflammation beneath the endothelium

immune system

heart inflammation ( J:106446 )

• by 25 months, 5 of 55 homozygotes exhibiting fibrosis of the aortic root also show evidence of inflammation beneath the endothelium

increased susceptibility to infection ( J:106446 )

• by 25 months of age, homozygotes are likely to suffer from some type of infection

homeostasis/metabolism

abnormal thrombosis ( J:106446 )

• 2 of 55 aging homozygotes exhibit an organized thrombus in a major vessel

neoplasm

increased tumor incidence ( J:106446 )

• by 25 months of age, homozygotes are likely to exhibit neoplasias of some kind

• 17 of 28 female homozygotes develop some type of tumor, with several females dying of cancer before the onset of cardiac fibrosis

• in contrast, only 9 of 27 male homozygotes develop a tumor, indicating that mutant females are more susceptible to tumor formation than males

cellular

cardiac interstitial fibrosis ( J:106446 )

• aging homozygotes of both sexes are more likely to develop severe cardiac fibrosis than wild-type mice; the number of affected male and female homozygotes is similar

• in addition, 5 of 55 homozygotes also exhibit fibrosis around major cardiac vessels or the aortic root

Allelic Composition	Wrn^tm1Led/Wrn⁺
Genetic Background	involves: 129S6/SvEvTac * Black Swiss

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Wrn^tm1Led mutation (0 available); any Wrn mutation (91 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

cardiac interstitial fibrosis ( J:106446 )

• by 25 months, 43% of heterozygotes vs 15% of wild-type littermates display cardiac interstitial fibrosis of the left ventricle

• in addition, 1 of 21 heterozygotes also exhibit fibrosis of the aortic root, not observed in wild-type mice

cellular

cardiac interstitial fibrosis ( J:106446 )

• by 25 months, 43% of heterozygotes vs 15% of wild-type littermates display cardiac interstitial fibrosis of the left ventricle

• in addition, 1 of 21 heterozygotes also exhibit fibrosis of the aortic root, not observed in wild-type mice

Allelic Composition	Trp53^tm1Brd/Trp53^tm1Brd Wrn^tm1Led/Wrn^tm1Led
Genetic Background	either: (involves: 129S/SvEv) or (involves: 129S/SvEv * NIH Black Swiss)

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53^tm1Brd mutation (5 available); any Trp53 mutation (232 available)
Wrn^tm1Led mutation (0 available); any Wrn mutation (91 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:68488 )

• 50% of mice by the age of 3 months developed tumors

decreased tumor latency ( J:68488 )

• an acceleration of tumorigenesis, in comparison to Wrn^tm1Led homozygous mice

Allelic Composition	Cdkn1a^tm1Led/Cdkn1a^tm1Led Wrn^tm1Led/Wrn^tm1Led
Genetic Background	either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss)

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdkn1a^tm1Led mutation (1 available); any Cdkn1a mutation (60 available)
Wrn^tm1Led mutation (0 available); any Wrn mutation (91 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:68488 )

• 56% of mice older than 15 months developed hyperplasias or tumors

• no acceleration of tumorigenesis, in comparison to Wrn^tm1Led homozygous mice

Allelic Composition	Tg(Hba-x-v-Ha-ras)TG.ACLed/0 Wrn^tm1Led/Wrn^tm1Led
Genetic Background	involves: 129 * FVB/N * Black Swiss

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Hba-x-v-Ha-ras)TG.ACLed mutation (1 available)
Wrn^tm1Led mutation (0 available); any Wrn mutation (91 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased incidence of tumors by chemical induction ( J:79056 )

• increased skin and fore-stomach papilloma incidence after TPA-treatment

increased papilloma incidence ( J:79056 )

• increased fore-stomach papilloma incident with or without TPA-treatment

• increased skin papilloma incidence after TPA-treatment

growth/size/body

weight loss ( J:79056 )

• dramatic weight loss between 6 and 8 months of age

• weight loss accompanies fore-stomach papilloma development

homeostasis/metabolism

increased incidence of tumors by chemical induction ( J:79056 )

• increased skin and fore-stomach papilloma incidence after TPA-treatment

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/16/2024 MGI 6.23